Have you helped conduct a clinical trial in Africa?
AC³T: Access through Clinical Trials
Under the purview of AAI, BVGH launched the African Consortium for Cancer Clinical Trials (AC³T) to foster and implement cancer clinical trials led by investigators in Africa. AC³T is designed to build clinical trial capacity and address the cancer data gap in Africa while increasing access to prioritized cancer diagnostics, medicines, and quality treatment for African patients.
> Increase access to new and established cancer medicines and technologies through clinical trials.
> Address the cancer data gap in African ethnicities.
> Galvanize support for African investigator-initiated cancer clinical trials at "ready now" cancer centers and hospitals.
> Build clinical trial capacity in "ready soon" cancer centers and hospitals.